Navigation Links
US Oncology Reports First Quarter 2008 Results
Date:5/7/2008

emi-annual interest payments on the indebtedness of US Oncology.

As of May 6, 2008, the Company had $148.0 million of cash and investments, and availability under the revolving credit facility of $133.7 million.

Development

One of the Company's ongoing objectives is to expand our network by affiliating with practices in new or existing markets, recruiting physicians into existing affiliated practices and entering into joint ventures. In the first quarter of 2008, our network grew by 48 physicians, net of retirements and other separations. During the same period, agreements were signed with 35 physicians to begin practicing in our network. An additional 30 physicians signed either CSA or OPS agreements during April, 2008 to join the US Oncology network.

Contingencies and Risks

During the fourth quarter of 2005, we received a subpoena from the United States Department of Justice's Civil Litigation Division ("DOJ") requesting a broad range of information about us and our business, generally in relation to our contracts and relationships with pharmaceutical manufacturers. We are cooperating fully with the DOJ in responding to the subpoena. At the present time, the DOJ has not made any allegation of wrongdoing on the part of the Company. We cannot, however, provide assurance that such an allegation or litigation will not result from this investigation.

On April 18, 2006, the Company terminated its net revenue model comprehensive service agreement with a practice in Oklahoma, as a result of alleged breaches of that agreement by the practice. The practice accounted for 4.6 percent and 2.3 percent of the Company's revenue and Adjusted EBITDA, respectively, for the first quarter of 2006. The Company remains in litigation with this practice regarding termination of its service agreement. As a result of the practice's alleged breaches of that agreement and the litigation, we were unable to collect payments on receivables owned by us an
'/>"/>

SOURCE US Oncology Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
2. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
3. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
4. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
5. US Oncology to Report 2007 Third Quarter Earnings Results
6. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
7. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
8. Varian Medical Systems Ranks First in Overall Service Performance in 2007 Survey of U.S. Radiation Oncology Professionals
9. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
10. Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology
11. National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National Greening Your School Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , ... September 02, 2015 , ... ... combining both naturopathic and allopathic medicine, opens its second location this week at ... features roughly 1000 square feet of lounge space for patients to relax while ...
(Date:9/2/2015)... , ... September 02, 2015 ... ... nation’s largest and fastest-growing interim clinical staffing companies, has completed a recapitalization ... Group.         , BPOC and Heritage Group each offer extensive expertise ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... announced today. The two day international investment and business conference will be hosted ... 2015 in Beijing China. The full-weekend networking conference will feature leading EB-5 industry ...
(Date:9/2/2015)... ... September 02, 2015 , ... World Patent Marketing, a vertically ... safety invention that protects people from crime and other hostile situations. , "The ... CEO and Creative Director of World Patent Marketing. "The industry is growing at ...
(Date:9/2/2015)... ... September 02, 2015 , ... EDAC Systems, Inc., a leading ... and services to both government and commercial clients, today announced the release of ... IBM’s Datacap document capture platform. EDAC PurePAGE processes and enhances the images ...
Breaking Medicine News(10 mins):Health News:The Hydration Room Opens New Location In Laguna Beach, California 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 4Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3
... the University of East Anglia have found that gold ... particles they say reveal the presence of poisons far ... back to a lab. This they hope would help ... led by Professor David Russell use of gold nanoparticles ...
... health care despite the fact that health care expenditure ... the results of a multi-national survey that was concluded ... that United States had spent $6,280 per capital on ... countries. ,US patients reported more diagnostic errors, ...
... out of 800 samples sent to a lab from ... for bird flu, official sources say.//, ,The samples ... sent till March 17 from Burhanpur, Barwani, Khargone, Jhabua, Balaghat, ... shadow of bird flu that broke out in Jalgaon district ...
... New Delhi. The Delhi High Court Monday issued notice ... Delhi government on a public interest litigation seeking legal// ... through a repeal of section 377 of the Indian ... is a criminal offence and punishable with imprisonment up ...
... Women approaching menopause are likely to face depression, says a ... treatment.//, ,Depression is a substantial illness with significant morbidity ... that can be managed, reports the health portal WebMd. , ... Massachusetts General Hospital studied 460 Boston women aged 36 to ...
... it has been found that if there is Intrahepatic cholestasis ... on.// ,This case control study was performed ... result. Intrahepatic cholestasis of pregnancy (ICP) is an itchy skin ... ,The study is published in the April 2006 issue ...
Cached Medicine News:Health News:Gold Nanoparticles Are Good Detectors Biological Toxins 2Health News:Intrahepatic cholestasis during pregnancy predisposes to later liver disease 2
(Date:9/2/2015)... Sept. 2, 2015 /PRNewswire/ -- VolitionRx Limited (NYSE MKT: VNRX), ... for a broad range of cancer types and other conditions, ... , is scheduled to present at the 17 th ... 8-10, 2015 in New York, NY . ... will be presenting at the CNAPS (Circulating Nucleic Acids ...
(Date:9/2/2015)... JUNCTION, N.J. , Sept. 2, 2015 ... immunotherapy leader commercializing its CytoSorb ® blood purification ... around the world, announced that CEO Dr. Phillip ... & Renshaw Annual Global Investment Conference (sponsored by ... 8-10 th in New York City.  ...
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of the "Pharmaceutical Regulatory ... - October 18-19, 2015)" conference to their ... Compliance with Regulatory Requirements Particularly relevant ... and Document Management Functions & Regulatory Authorities ...
Breaking Medicine Technology:VolitionRx to Present at Rodman & Renshaw 17th Annual Global Investment Conference in New York and CNAPS IX Conference in Berlin on September 9 and 11, 2015 2VolitionRx to Present at Rodman & Renshaw 17th Annual Global Investment Conference in New York and CNAPS IX Conference in Berlin on September 9 and 11, 2015 3VolitionRx to Present at Rodman & Renshaw 17th Annual Global Investment Conference in New York and CNAPS IX Conference in Berlin on September 9 and 11, 2015 4CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference 2CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference 3CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference 4Pharmaceutical Regulatory Affairs Course in the Middle East, Dubai (Dubai, UAE - October 18-19, 2015) 2
... , PRINCETON, N.J., Sept. 24 DOR BioPharma, ... a late-stage biotechnology company, announced today that it has entered ... $3.85 million. DOR,s North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., ... Under the terms of the agreements, DOR will sell approximately ...
... Sept. 24 Cephalon, Inc. (Nasdaq: CEPH ) ... granted a priority review for its supplemental New Drug Application ... in June of this year. The FDA decision on approval ... with excessive sleepiness associated with jet lag disorder due to ...
Cached Medicine Technology:DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors 2DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors 3DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors 4Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder 2Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder 3Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder 4
...
...
... At the entry-level, Philips Zymed 1810 Series ... preview, which gives the operator the flexibility ... complex arrhythmia. Choose an application beyond the ... flexibility. Select the interactive or automatic style ...
... Zymed 2010 plus Holter Software for ... application as easy to install, use ... data presentation as comprehensive as a ... superimposition, prospective paging and QuickScan, which ...
Medicine Products: